AbbVie to Ring in 2013 as an Independent Drugmaker

Published: Thursday, November 29th 2012

(Fierce) - AbbVie has its final stamp of approval. Abbott Laboratories' ($ABT) directors endorsed the pharma unit's spinoff Wednesday, allowing AbbVie to ring in the new year as an independent company.

Read more.

Comment(s)

Your comments are valuable to us. Thank you.

Abbott Spinoff AbbVie Begins Trading to Determine Value

Abbott Unit Sells $14.7 Billion of Bonds Ahead of Split

AbbVie Rises on First Day of Trading After Abbott Spinoff

Abbott’s Exec Gets Pass on Padded Resume

FDA Staff Does Not Recommend Approval of Abbott's Heart Device